Phase II study of cabazitaxel with or without abiraterone acetate and prednisone in patients with metastatic castrate resistant prostate cancer after prior docetaxel and abiraterone acetate.

Ann Oncol

Division of Medical Oncology, University of Colorado, School of Medicine, University of Colorado Cancer Center, Aurora, Colorado, USA.

Published: March 2017

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075473	PMC
http://dx.doi.org/10.1093/annonc/mdw674	DOI Listing

Publication Analysis

abiraterone acetate

phase study

study cabazitaxel

cabazitaxel abiraterone

acetate prednisone

prednisone patients

patients metastatic

metastatic castrate

castrate resistant

resistant prostate

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!